Neurosigma, Inc.

Los Angeles, CA

UEI
RVTRYKNAUET3
CAGE
5EL66
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
10960 Wilshire Blvd #1910, Los Angeles, CA 90024, USA
Website
neurosigma.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Development of an anti-embolic micromesh carotid stent R43HL140895 National Heart Lung and Blood Institute (NIH) $415,743
Development of an implantable trigeminal nerve stimulation system for drug resist U44NS081840 National Institute of Neurological Disorders and Stroke (NIH) $2,596,921
Trigeminal nerve stimulation for epilepsy R41NS076014 National Institutes of Health $746,869
Preclinical testing of a novel flow diverting stent for the treatment of intracra R41NS074576 National Institutes of Health $682,537
Preclinical testing of a novel flow diverting stent for treating intracranial aneurysms R42NS074576 National Institute of Neurological Disorders and Stroke (NIH) $2,949,208

Quick answers

Is Neurosigma, Inc. registered in SAM.gov?

Yes. Neurosigma, Inc.'s SAM.gov registration is active through November 24, 2026.

What is Neurosigma, Inc.'s most recent federal award?

Neurosigma, Inc.'s most recent federal grant award is Development of an anti-embolic micromesh carotid stent (R43HL140895), from National Heart Lung and Blood Institute (NIH), on September 20, 2018.

On GovTribe

See Neurosigma, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login